News

News

JAMA Editor-in-Chief Resigns After Releasing Content Questioning Racism in Medicine

In late June, Howard Bauchner, MD, will resign from his role as editor-in-chief of the Journal of the American Medical Association (JAMA) following a...

Will DIY Testing Outlive the COVID-19 Pandemic?

The COVID-19 pandemic has revolutionized diagnostic testing. As the pandemic eases and related restrictions are lifted, public health officials and scientists are looking to...

FDA Approves Pegcetacoplan for Paroxysmal Nocturnal Hemoglobinuria

The U.S. Food and Drug Administration (FDA) has approved the targeted C3 inhibitor pegcetacoplan for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria...

FDA Clears IND Application for Gamma Delta T-Cell Therapy

The U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for GDX012 to be examined as a therapy for...

Biden Administration Requests $13.5 Billion Increase in Scientific Research Spending

As part of the administration’s $6 trillion budget request for the 2022 fiscal year, President Joe Biden has proposed a 9% increase, or $13.5...

FDA Brings Back Unapproved Drugs Initiative

The U.S. Food and Drug Administration (FDA) is reversing the Trump administration’s decision to end the Unapproved Drugs Initiative. This program, which launched in 2006,...

Umbralisib Demonstrates Long-Term Safety and Clinical Activity in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

Patients with relapsed or refractory indolent non-Hodgkin lymphoma (iNHL) have historically had poor long-term tolerance to phosphatidylinositol-3-kinase (PI3K) inhibitors. However, new study results published...

Does Rheumatic Disease Increase Risk of MGUS Progression to Hematologic Malignancies?

Patients with monoclonal gammopathy of undetermined significance (MGUS) and concomitant non-antibody (Ab)–mediated inflammatory rheumatic diseases are at increased risk of progression to overt multiple...

More COVID-19 Complications Seen in Black Patients With Sickle Cell Disease and Sickle Cell...

Patients with sickle cell disease (SCD) and sickle cell trait (SCT) have significantly higher rates of hospitalization, pneumonia, and pain related to COVID-19 compared...
ASH Directions

ASH Minority Recruitment Initiative Seeks Mentors, ASH Joins in Support of the Federal Safe...

Mentors Needed for ASH Minority Recruitment Initiative The American Society of Hematology (ASH) Minority Recruitment Initiative (MRI), which was created nearly two decades ago to...
Advertisement

Current Issue

June 2021 Volume 7 Issue 7

This issue reviews the management and prevention of peripheral neuropathy, early successes of SCD screening programs in sub-Saharan Africa, and more.

Block title